
New FDA Drug-testing Guidelines Open Door for Use of Data
Generated by Microfluidic Organ-On-A-Chip Devices For decades the U.S. Food and Drug Administration has depended upon results from animal trials to prove the safety and efficacy of pharmaceuticals. Yet the methodology is far from reliable. Only 10% of the drugs that move from animal testing to human clinical trials succeeds. Such low yields from a...